Patents by Inventor Ragna Sannerud

Ragna Sannerud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GAMMA-SECRETASE STABILIZING COMPOUND SCREENING ASSAY
    Publication number: 20220397566
    Abstract: Current application relates to the field of neurodegenerative diseases. More specifically, the present invention relates to screening methods to identify compounds that can reduce the production of amyloidogenic Amyloid beta fragments. Said compounds can be used in treatments of for example Alzheimer's disease.
    Type: Application
    Filed: November 16, 2020
    Publication date: December 15, 2022
    Inventors: Wim Annaert, Ragna Sannerud
  • Screening methods for compounds that modulate ARF-6 mediated endosomal redistribution
    Patent number: 8790887
    Abstract: The invention relates to the field of disorders of the peripheral or central nervous system, in particular, Alzheimer's disease, and the prevention and/or treatment thereof. In particular, the invention relates to ARF6 and/or ARF6 effector proteins as new targets in Alzheimer's disease, and based thereon, screening methods for compounds that reduce amyloid beta peptide formation in mammalian cells by affecting ARF6-mediated endosomal sorting.
    Type: Grant
    Filed: December 6, 2010
    Date of Patent: July 29, 2014
    Assignees: VIB VZW, Katholieke Universiteit Leuven, K.U. Leuven R&D
    Inventors: Wim Annaert, Ragna Sannerud, Katrijn Coen, Bart De Strooper
  • ARF6 AS A NEW TARGET FOR TREATING ALZHEIMER'S DISEASE
    Publication number: 20120276076
    Abstract: The invention relates to the field of disorders of the peripheral or central nervous system, in particular, Alzheimer's disease, and the prevention and/or treatment thereof. In particular, the invention relates to ARF6 and/or ARF6 effector proteins as new targets in Alzheimer's disease, and based thereon, screening methods for compounds that reduce amyloid beta peptide formation in mammalian cells by affecting ARF6-mediated endosomal sorting.
    Type: Application
    Filed: December 6, 2010
    Publication date: November 1, 2012
    Applicants: KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D, VIB VZW
    Inventors: Wim Annaert, Ragna Sannerud, Katrijn Coen, Bart De Strooper